LEO Pharma A/S
5 products tracked · names used in filings: LEO Pharma A/S
Upcoming milestones
No upcoming milestones listed.
Recent milestones
No recent milestones.
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Anzupgo delgocitinib | Authorised | 2024-09-19 |
| 🇪🇺 | Spevigo spesolimab | Authorised | 2022-12-09 |
| 🇪🇺 | Adtralza tralokinumab | Authorised | 2021-06-17 |
| 🇪🇺 | Kyntheum brodalumab | Authorised | 2017-07-17 |
| 🇪🇺 | Protopic tacrolimus | Authorised | 2002-02-27 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.